Search Press releases Keywords From To 1 Dec 2023 UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting Read More 23 Nov 2023 Transparency notification Wellington Read More 16 Nov 2023 ‘Rheumacensus’ experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements Read More 11 Nov 2023 Post hoc analysis showed meaningful efficacy of certolizumab pegol for RA patients with high Rheumatoid Factor (RF) levels Read More 10 Nov 2023 UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe Read More 10 Nov 2023 UCB Presents New Five-Year Data on BIMZELX[®]▼(bimekizumab) in Ankylosing Spondylitis at ACR Convergence 2023 Read More Pagination First page Previous page Previous … Page 26 Page 27 Page 28 Page 29 Current page 30 Page 31 Page 32 Page 33 Page 34 … Page 30 of 65 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
